CIHR: Bringing Rare Disease Gene Therapies to Clinical Trial Readiness
Research Admin Offices:
- HRS
Funding Type:
GrantOpportunity Type:
- Grant
Value:
Up to $1,137,500 over four years.
Disciplines:
- Health Sciences
Sponsors:
Deadlines:
Internal Deadline:
September 6, 2023Sponsor Deadline:
September 20, 2023Additional Dates:
- HRS LOI Due Date - September 6, 2023
- Sponsor LOI Due Date - September 20, 2023
- Sponsor Application Due Date (by invitation) - February 13, 2024
Description:
This opportunity supports research to bridge the current gap between model organisms/systems and clinical trials for rare disease drugs in Canada, ultimately increasing the capacity to bring gene therapies to clinic.
Resources:
Contact:
If applying from the Faculty of Health Sciences, unless otherwise indicated, you no longer need to send documents to HRS Intake. Your first point of contact is your assigned Senior Grants Advisor.